NO20091788L - Antibakterielle og antivirale peptider fra Actinomadura namibiensis - Google Patents

Antibakterielle og antivirale peptider fra Actinomadura namibiensis

Info

Publication number
NO20091788L
NO20091788L NO20091788A NO20091788A NO20091788L NO 20091788 L NO20091788 L NO 20091788L NO 20091788 A NO20091788 A NO 20091788A NO 20091788 A NO20091788 A NO 20091788A NO 20091788 L NO20091788 L NO 20091788L
Authority
NO
Norway
Prior art keywords
independently
antibacterial
formula
amino acid
amino acids
Prior art date
Application number
NO20091788A
Other languages
English (en)
Norwegian (no)
Inventor
Irvin Winkler
Gerhard Seibert
Joachim Wink
Laszl0 Vertesy
Roderich Sussmuth
George Sheldrick
Kathrin Meindl
Mark Broenstrup
Holger Hoffmann
Hans Guehring
Luigi Toti
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37836831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091788(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20091788L publication Critical patent/NO20091788L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20091788A 2006-10-06 2009-05-05 Antibakterielle og antivirale peptider fra Actinomadura namibiensis NO20091788L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06020980A EP1908774A1 (fr) 2006-10-06 2006-10-06 Peptides antibactériens et antiviraux isolées du Actinomadura namibiensis
PCT/EP2007/008294 WO2008040469A1 (fr) 2006-10-06 2007-09-25 Peptides antibacteriens et antiviraux issus d'actinomadura namibiensis

Publications (1)

Publication Number Publication Date
NO20091788L true NO20091788L (no) 2009-06-24

Family

ID=37836831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091788A NO20091788L (no) 2006-10-06 2009-05-05 Antibakterielle og antivirale peptider fra Actinomadura namibiensis

Country Status (21)

Country Link
US (1) US8476222B2 (fr)
EP (2) EP1908774A1 (fr)
JP (1) JP5204779B2 (fr)
KR (1) KR101504492B1 (fr)
CN (1) CN101522705B (fr)
AR (1) AR063140A1 (fr)
AT (1) ATE525389T1 (fr)
AU (1) AU2007304536B2 (fr)
BR (1) BRPI0719978A2 (fr)
CA (1) CA2665269C (fr)
CL (1) CL2007002889A1 (fr)
IL (1) IL197971A (fr)
MA (1) MA31133B1 (fr)
MX (1) MX2009002962A (fr)
MY (1) MY147920A (fr)
NO (1) NO20091788L (fr)
NZ (1) NZ576039A (fr)
RU (1) RU2451028C2 (fr)
UY (1) UY30629A1 (fr)
WO (1) WO2008040469A1 (fr)
ZA (1) ZA200901321B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0910985A2 (pt) * 2008-04-02 2019-09-24 Sanofi Aventis peptídeos de actinomadura namibiensis altamente ligados em ponte
EP2607374A1 (fr) 2011-12-21 2013-06-26 Sanofi Procédé de production recombinante de labyrintho-peptines et dérivés fonctionnels associés
CN103421100B (zh) * 2012-05-22 2015-11-18 中国科学院动物研究所 一种抗菌肽及其制备方法和应用
US10487124B2 (en) 2012-07-12 2019-11-26 Naicons S.R.L. Lantipeptide
WO2017085257A1 (fr) 2015-11-18 2017-05-26 Helmholtz-Zentrum für Infektionsforschung GmbH Labyrinthopeptines utilisées comme agents antiviraux
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途
CN110400607B (zh) * 2019-07-17 2020-06-02 杭州费尔斯通科技有限公司 一种分子式库的扩展方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19745583A1 (de) * 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
BRPI0910985A2 (pt) * 2008-04-02 2019-09-24 Sanofi Aventis peptídeos de actinomadura namibiensis altamente ligados em ponte

Also Published As

Publication number Publication date
US8476222B2 (en) 2013-07-02
CA2665269A1 (fr) 2009-04-02
CN101522705B (zh) 2013-10-02
EP2076529A1 (fr) 2009-07-08
BRPI0719978A2 (pt) 2014-08-12
MY147920A (en) 2013-02-15
KR20090075679A (ko) 2009-07-08
KR101504492B1 (ko) 2015-03-23
JP5204779B2 (ja) 2013-06-05
US20090298904A1 (en) 2009-12-03
JP2010505777A (ja) 2010-02-25
WO2008040469A1 (fr) 2008-04-10
IL197971A (en) 2015-08-31
IL197971A0 (en) 2011-08-01
AR063140A1 (es) 2008-12-30
CL2007002889A1 (es) 2008-04-18
ZA200901321B (en) 2009-12-30
AU2007304536B2 (en) 2012-08-23
HK1135708A1 (en) 2010-06-11
MA31133B1 (fr) 2010-02-01
CN101522705A (zh) 2009-09-02
EP2076529B1 (fr) 2011-09-21
ATE525389T1 (de) 2011-10-15
AU2007304536A1 (en) 2008-04-10
EP1908774A1 (fr) 2008-04-09
RU2009117220A (ru) 2010-11-20
MX2009002962A (es) 2009-04-01
UY30629A1 (es) 2008-05-31
NZ576039A (en) 2011-07-29
CA2665269C (fr) 2015-07-14
RU2451028C2 (ru) 2012-05-20

Similar Documents

Publication Publication Date Title
NO20091788L (no) Antibakterielle og antivirale peptider fra Actinomadura namibiensis
BR0315937A (pt) Composto, composição para a profilaxia ou tratamento de infecções virais, e, método para a profilaxia ou tratamento de infecções da hepatite c e doenças associadas com tais infecções em um hospedeiro vivo
NO20071369L (no) Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
RU2011140057A (ru) Способ профилактики и лечения повышенной проницаемости
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
EA201190292A1 (ru) Улучшенная композиция реконструированных сурфактантов, содержащая аналоги сурфактантного белка в (sp-b) и сурфактантного белка с (sp-c)
CO5700785A2 (es) Composiciones inmunogenicas novedosas para la prevencion y el tratamiento de enfermedad meningococal
BR0305426A (pt) Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos
WO2008081701A1 (fr) Peptide wt1 à restriction hla-a*1101 et composition pharmaceutique le contenant
BR0212008A (pt) Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste
BRPI0413276B8 (pt) derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
BRPI0414062B8 (pt) uso de ciclosporinas modificadas para o tratamento de distúrbios por hcv
BRPI0511421A (pt) composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo
CN110563802B (zh) 一组含n-甲基化氨基酸及n端脂肪酸修饰的抗菌肽类似物及其合成方法和应用
MX341317B (es) Proteinas de elastasa recombinantes y metodos de fabricacion y uso de las mismas.
ATE457353T1 (de) Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon
Caiaffa et al. Effect of analogues of cationic peptides on dentin mineralization markers in odontoblast-like cells
ATE503768T1 (de) Synthetische lungensurfactant peptide
JP2020527159A5 (fr)
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
ITMI20031144A1 (it) Analoghi del colchicoside.
DE60224280D1 (de) Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application